284 related articles for article (PubMed ID: 18223461)
1. Clozapine and norclozapine concentrations in serum and plasma samples from schizophrenic patients.
Hermida J; Paz E; Tutor JC
Ther Drug Monit; 2008 Feb; 30(1):41-5. PubMed ID: 18223461
[TBL] [Abstract][Full Text] [Related]
2. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.
Spina E; Avenoso A; Facciolà G; Scordo MG; Ancione M; Madia AG; Ventimiglia A; Perucca E
Psychopharmacology (Berl); 2000 Jan; 148(1):83-9. PubMed ID: 10663421
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic drug monitoring of clozapine and norclozapine in human serum using ultra-performance liquid chromatography- tandem mass spectrometry.
Ming DS; Heathcote J
J Anal Toxicol; 2009 May; 33(4):198-203. PubMed ID: 19470221
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of clozapine and norclozapine in Mexican schizophrenia patients.
González-Esquivel DF; Castro N; Ramírez-Bermúdez J; Custodio V; Rojas-Tomé S; Castro-Román R; Jung-Cook H
Arzneimittelforschung; 2011; 61(6):335-9. PubMed ID: 21827043
[TBL] [Abstract][Full Text] [Related]
5. Retrospective evaluation of therapeutic drug monitoring of clozapine and norclozapine in Belgium using a multidrug UHPLC-MS/MS method.
Patteet L; Maudens KE; Vermeulen Z; Dockx G; De Doncker M; Morrens M; Sabbe B; Neels H
Clin Biochem; 2014 Dec; 47(18):336-9. PubMed ID: 25289972
[TBL] [Abstract][Full Text] [Related]
6. Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993-2007.
Couchman L; Morgan PE; Spencer EP; Flanagan RJ
Ther Drug Monit; 2010 Aug; 32(4):438-47. PubMed ID: 20463634
[TBL] [Abstract][Full Text] [Related]
7. CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia.
Ozdemir V; Kalow W; Posner P; Collins EJ; Kennedy JL; Tang BK; Albers LJ; Reist C; Roy R; Walkes W; Afra P
J Clin Psychopharmacol; 2001 Aug; 21(4):398-407. PubMed ID: 11476124
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients.
Aravagiri M; Marder SR
J Pharm Biomed Anal; 2001 Sep; 26(2):301-11. PubMed ID: 11470207
[TBL] [Abstract][Full Text] [Related]
9. A novel approach to quantitative LC-MS/MS: therapeutic drug monitoring of clozapine and norclozapine using isotopic internal calibration.
Couchman L; Belsey SL; Handley SA; Flanagan RJ
Anal Bioanal Chem; 2013 Nov; 405(29):9455-66. PubMed ID: 24091736
[TBL] [Abstract][Full Text] [Related]
10. Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients.
Perry PJ; Miller DD; Arndt SV; Cadoret RJ
Am J Psychiatry; 1991 Feb; 148(2):231-5. PubMed ID: 1670979
[TBL] [Abstract][Full Text] [Related]
11. Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia.
Xiang YQ; Zhang ZJ; Weng YZ; Zhai YM; Li WB; Cai ZJ; Tan QR; Wang CY
Schizophr Res; 2006 Apr; 83(2-3):201-10. PubMed ID: 16524698
[TBL] [Abstract][Full Text] [Related]
12. Effect of post-mortem changes on peripheral and central whole blood and tissue clozapine and norclozapine concentrations in the domestic pig (Sus scrofa).
Flanagan RJ; Amin A; Seinen W
Forensic Sci Int; 2003 Mar; 132(1):9-17. PubMed ID: 12689746
[TBL] [Abstract][Full Text] [Related]
13. Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking.
Hasegawa M; Gutierrez-Esteinou R; Way L; Meltzer HY
J Clin Psychopharmacol; 1993 Dec; 13(6):383-90. PubMed ID: 8120151
[TBL] [Abstract][Full Text] [Related]
14. Clozapine and Norclozapine Concentrations in Paired Human Plasma and Serum Samples.
Sa H; Fisher SS; K S; Rj F
Ther Drug Monit; 2018 Feb; 40(1):148-150. PubMed ID: 29240616
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome and plasma levels of clozapine and norclozapine in drug-resistant schizophrenic patients.
Mauri M; Volonteri LS; Fiorentini A; Invernizzi G; Nerini T; Baldi M; Bareggi SR
Schizophr Res; 2004 Feb; 66(2-3):197-8. PubMed ID: 15061256
[No Abstract] [Full Text] [Related]
16. Solid-phase extraction and high-performance liquid chromatographic analysis of clozapine and norclozapine in human plasma.
Freeman DJ; Li MC; Oyewumi K
Ther Drug Monit; 1996 Dec; 18(6):688-92. PubMed ID: 8946666
[TBL] [Abstract][Full Text] [Related]
17. Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics.
Lane HY; Chang YC; Chang WH; Lin SK; Tseng YT; Jann MW
J Clin Psychiatry; 1999 Jan; 60(1):36-40. PubMed ID: 10074876
[TBL] [Abstract][Full Text] [Related]
18. A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions.
Tan MSA; Honarparvar F; Falconer JR; Parekh HS; Pandey P; Siskind DJ
Psychopharmacology (Berl); 2021 Mar; 238(3):615-637. PubMed ID: 33410989
[TBL] [Abstract][Full Text] [Related]
19. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia.
Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS
Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241
[TBL] [Abstract][Full Text] [Related]
20. Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders.
Facciolà G; Avenoso A; Scordo MG; Madia AG; Ventimiglia A; Perucca E; Spina E
Ther Drug Monit; 1999 Jun; 21(3):341-5. PubMed ID: 10365650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]